SXC completes $100 million buyout of MedfusionRx
Pharmacy benefits manager SXC Health Solutions Corp. said Wednesday it completed the buyout of specialty pharmacy provider MedfusionRx LCC for $100 million.
The company announced the buyout Dec. 2. The deal includes up to an additional $5.5 million if certain performance targets are achieved through the 2012 fiscal year.
MedfusionRx is based in Birmingham, Ala., and provides clinical services to more than 9,000 patients with complex clinical conditions, including cancer, multiple sclerosis and hepatitis. SXC expects the deal to generate between 15 cents and 17 cents in adjusted earnings next year.